Ontology highlight
ABSTRACT: Background
Topical corticosteroid (TCS) treatment is widely prescribed for atopic dermatitis (AD). However, TCS treatment is associated with tachyphylaxis, and discontinuation after long-term use may cause exacerbation of symptoms. Some AD patients are reluctant to use TCS.Objective
To evaluate patient-reported short- and long-term outcomes after discontinuation of TCS treatment for AD.Methods
Questionnaires were distributed to adult AD patients (n=1,812) of doctors who did not recommend TCS as first-line therapy for patients who preferred to avoid TCS. Data collected included current TCS use, duration of TCS use, past discontinuation of TCS use, exacerbation of symptoms after discontinuation of TCS use, and limitations to daily activities because of AD.Results<
SUBMITTER: Takahashi-Ando N
PROVIDER: S-EPMC4396455 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature